DrugPatentWatch Database Preview
Drugs in Development Information for AGN-201904
» See Plans and Pricing
What is the drug development status for AGN-201904?
AGN-201904 is an investigational drug.
There have been 49 clinical trials for AGN-201904.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2014.
The most common disease conditions in clinical trials are Ocular Hypertension, Presbyopia, and Glaucoma, Open-Angle. The leading clinical trial sponsors are Allergan, Editas Medicine, Inc., and Naurex, Inc, an affiliate of Allergan plc.
There are two US patents protecting this investigational drug and forty-three international patents.
Summary for AGN-201904
| US Patents | 2 |
| International Patents | 43 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2014-05-01) |
| Vendors | 1 |
Recent Clinical Trials for AGN-201904
| Title | Sponsor | Phase |
|---|---|---|
| AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension | Allergan | Phase 1/Phase 2 |
| Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia | Allergan | Phase 1/Phase 2 |
| A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease | Allergan | Phase 1/Phase 2 |
Clinical Trial Summary for AGN-201904
Top disease conditions for AGN-201904
Top clinical trial sponsors for AGN-201904
US Patents for AGN-201904
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AGN-201904 | Start Trial | Prodrugs of proton pump inhibitors | Winston Pharmaceuticals, Inc. (Newport Beach, CA) The United States of America as represented by the Department of Veteran Affairs (Washington, DC) N/A (Oakland, CA) The Reagents of the University of California (N/A) | Start Trial |
| AGN-201904 | Start Trial | Process for preparing isomerically pure prodrugs of proton pump inhibitors | Allergan, Inc. (Irvine, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AGN-201904
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AGN-201904 | Argentina | 042513 | 2022-07-19 | Start Trial |
| AGN-201904 | Austria | 323695 | 2022-07-19 | Start Trial |
| AGN-201904 | Australia | 2003259154 | 2022-07-19 | Start Trial |
| AGN-201904 | Brazil | 0312802 | 2022-07-19 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
